Enveric Biosciences Inc
(ENVB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 1,874 | 2,519 | 2,188 | 3,174 | 2,083 |
| Operating Income | -1,874 | -2,519 | -2,188 | -3,174 | -2,083 |
| Other Income | 0 | 0 | 3 | 26 | -1 |
| Pre-tax Income | -1,874 | -2,519 | -2,185 | -3,147 | -2,084 |
| Income Tax | N/A | N/A | N/A | 7 | N/A |
| Net Income Continuous | -1,874 | -2,519 | -2,185 | -3,155 | -2,084 |
| Net Income | $-1,874 | $-2,519 | $-2,185 | $-3,155 | $-2,084 |
| EPS Basic Total Ops | -10.81 | -11.64 | -14.65 | -30.25 | -43.10 |
| EPS Basic Continuous Ops | -5.98 | -11.65 | -14.59 | -30.26 | -43.10 |
| EPS Diluted Total Ops | -10.81 | -11.64 | -14.65 | -30.25 | -43.10 |
| EPS Diluted Continuous Ops | -5.98 | -11.65 | -14.59 | -30.26 | -43.10 |
| EPS Diluted Before Non-Recurring Items | -10.81 | -11.65 | -14.65 | N/A | -43.20 |
| EBITDA(a) | $-1,834 | $-2,479 | $-2,107 | $-3,091 | $-1,998 |